Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a

被引：10
|
作者：
Leonardi, Craig L. [1 ]
机构：
[1] St Louis Univ, Cent Dermatol, Dermatol, St Louis, MO 63103 USA
来源：
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY | 2016年 / 35卷
关键词：
IL-12/23; inhibitors; IL-17/IL-17A inhibitors; IL-23; PLACEBO-CONTROLLED TRIAL; TO-SEVERE PSORIASIS; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; IL; 12/23; AGENTS; DOUBLE-BLIND; CARDIOVASCULAR EVENTS; PLAQUE PSORIASIS; METAANALYSES; USTEKINUMAB; SAFETY;
D O I：
10.12788/j.sder.2016.021
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The anti-tumor necrosis factor (TNF)-alpha agents represent the second generation of psoriasis therapy. Research has produced a third generation of biologic treatments, some of which offer greater efficacy than the TNF-alpha inhibitors. This article reviews the data documenting the efficacy and safety of three types of biologics. (C) 2016 published by Frontline Medical Communications
引用
收藏
页码：S74 / S77
页数：4
相关论文
共 50 条
  • [21] A Taql polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion
    Seegers, D
    Zwiers, A
    Strober, W
    Peña, AS
    Bouma, G
    GENES AND IMMUNITY, 2002, 3 (07) : 419 - 423
  • [22] Expression of IL-12 (p40) and IL-12 (β2) receptor in allergic rhinitis and chronic sinusitis.
    Wright, E
    Frenkiel, S
    Hamid, Q
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S233 - S233
  • [23] Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis A Case Series
    Shurey, Megan
    Yip, Ashley
    Ziouzina, Olga
    Chan, Jonathan
    Dutz, Jan P.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E626 - E628
  • [24] A HOMODIMER OF THE IL-12 P40 SUBUNIT BINDS TO THE IL-12 RECEPTOR BUT DOES NOT MEDIATE BIOLOGIC ACTIVITY
    LING, P
    LIN, P
    GUBLER, U
    PAN, YE
    GATELY, MK
    HAKIMI, J
    FASEB JOURNAL, 1994, 8 (04): : A506 - A506
  • [25] Anti IL-12/IL-23 p40 therapy inhibits epidermal activation in uninvolved psoriatic skin
    Baerveldt, Ewout
    Onderdijk, Armanda
    Kant, Marius
    Florencia, Eddy
    Gudjonsson, Johann
    Thio, Bing
    Laman, Jon
    Prens, Errol
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S44 - S44
  • [26] A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion
    D Seegers
    A Zwiers
    W Strober
    A S Peña
    G Bouma
    Genes & Immunity, 2002, 3 : 419 - 423
  • [27] Neutralisation of IL12 p40 or IL23 p40 does not block inflammation in multiple sclerosis
    Martin, Roland
    LANCET NEUROLOGY, 2008, 7 (09): : 765 - 766
  • [28] Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide
    Cowdery, JS
    Boerth, NJ
    Norian, LA
    Myung, PS
    Koretzky, GA
    JOURNAL OF IMMUNOLOGY, 1999, 162 (11): : 6770 - 6775
  • [29] Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
    Kyriakou, Aikaterini
    Patsatsi, Aikaterini
    Vyzantiadis, Timoleon-Achilleas
    Sotiriadis, Dimitrios
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014
  • [30] Characterization of an IL-12 p40/p35 Truncated Fusion Protein That Can Inhibit the Action of IL-12
    Skrombolas, Denise
    Wylie, Isabel
    Maharaj, Shivana
    Frelinger, John G.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2015, 35 (09): : 690 - 697
12345